Condition
Coronary Artery Disease
Coronary artery disease is the narrowing or blockage of the coronary arteries by atherosclerotic plaque, reducing blood flow to the heart muscle.
Overview
Aetiology
Dislipidemia
Abnormal concentrations of blood lipids can lead to the development of atherosclerosis, coronary artery plaques, and eventually coronary artery disease.
Risk Factors
- Smoking
- High blood pressure
- High cholesterol
- Diabetes or insulin resistance
- Sedentary lifestyle
- Genetic polymorphisms
- Age
- Gender (most common in males)
- Diet (high saturated fats and processed carbohydrates)
- Chronic stress
Presentation
Symptoms
The classic symptom is angina, a tight or heavy chest pain or discomfort that may radiate to the arm, neck, or jaw and is typically brought on by exertion or stress. Breathlessness and fatigue may also occur, and the disease can be silent until a heart attack develops.
Assessment
Diagnostic Considerations
Coronary artery calcification was shown to be the most reliable predictor of coronary heart disease over risk factor measures such as the Framingham Risk Score 1Reference 1Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project.
Assessment
Differential Diagnosis
- Myocardial infarction
Context
Comorbidities
- Diabetes
- Angina pectoris
- Stress
- heart attack
- Heart dysrhythmias
- Chronic heart failure
The Herbs
Materia Medica (4)
Herbs traditionally or clinically used for coronary artery disease.
Supplementation
Supplementation (3)
Supplements, nutrients and compounds used for coronary artery disease.
Liraglutide (Victoza / Saxenda)
GLP-1 receptor agonist
A prescription once-daily GLP-1 receptor agonist for type 2 diabetes and chronic weight management — the drug that established the class.
Semaglutide (Ozempic / Wegovy / Rybelsus)
GLP-1 receptor agonist
A prescription GLP-1 receptor agonist approved for type 2 diabetes, chronic weight management, and cardiovascular, renal and liver (MASH) risk reduction.
Tirzepatide (Mounjaro / Zepbound)
Dual GIP / GLP-1 receptor agonist ("twincretin")
A prescription dual GIP/GLP-1 receptor agonist approved for type 2 diabetes, chronic weight management, and obstructive sleep apnea with obesity.
References:
- Taylor, A. J., Bindeman, J., Feuerstein, I., Cao, F., Brazaitis, M., & O’Malley, P. G. (2005). Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. Journal of the American College of Cardiology, 46(5), 807-814.